Resultados globales: 1 registros encontrados en 0.03 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
9 p, 801.8 KB PD-1 Blockade in Anaplastic Thyroid Carcinoma / Capdevila Castillón, Jaume (Vall d'Hebron Institut d'Oncologia) ; Wirth, Lori J. (Harvard Medical School) ; Ernst, Thomas (Universitätsklinikum Jena) ; Ponce Aix, Santiago (Hospital Universitario 12 de Octubre (Madrid)) ; Lin, Chia-Chi (National Taiwan University Hospital (Taipei, Taiwan)) ; Ramlau, Rodryg (Poznań University of Medical Sciences) ; Butler, Marcus O. (Princess Margaret Cancer Centre) ; Delord, Jean-Pierre (IUCT Oncopole) ; Gelderblom, Hans J (Leiden University Medical Center) ; Ascierto, Paolo A. (Istituto Nazionale Tumori IRCCS Fondazione G. Pascale) ; Fasolo, Angelica (San Raffaele Hospital) ; Führer, Dagmar (University Hospital Essen (Alemanya)) ; Hütter-Krönke, Marie Luise (University Hospital of Ulm (Alemanya)) ; Forde, Patrick M. (Sidney Kimmel Comprehensive Cancer Center) ; Wrona, Anna (Uniwersyteckie Centrum Kliniczne) ; Santoro, Armando (IRCCS Humanitas University) ; Sadow, Peter M. (Harvard Medical School) ; Szpakowski, Sebastian (Novartis Institutes for BioMedical Research) ; Wu, Hongqian (Novartis Pharmaceuticals) ; Bostel, Geraldine (Novartis Institutes for BioMedical Research) ; Faris, Jason (Novartis Institutes for BioMedical Research) ; Cameron, Scott (Novartis Institutes for BioMedical Research) ; Varga, Andreea (Gustave Roussy Cancer Campus) ; Taylor, Matthew (Oregon Health & Science University) ; Universitat Autònoma de Barcelona
Anaplastic thyroid carcinoma is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options for patients with BRAF -wild type disease. As part of a phase I/II study in patients with advanced/metastatic solid tumors, patients with anaplastic thyroid carcinoma were treated with spartalizumab, a humanized monoclonal antibody against the programmed death-1 (PD-1) receptor. [...]
2020 - 10.1200/JCO.19.02727
Journal of Clinical Oncology, Vol. 38 Núm. 23 (may 2020) , p. 2620-2627  

Vea también: autores con nombres similares
1 Wu, H.
1 Wu, H. H.
1 Wu, Haijing
1 Wu, Han
1 Wu, Hannah
8 Wu, Hao
8 Wu, Hao
1 Wu, Hao Bin
1 Wu, He
2 Wu, Honghui
2 Wu, Hsiuan-Lin
1 Wu, Huidan
1 Wu, Huili
1 Wu, Hung-Chin
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.